Cardiovascular Combination Pharmacotherapy Global Summit

Date/time: 
08/05/2014 - 08:00
Event location: 

Melbourne Convention and Exhibition Centre

The polypill concept has generated widespread global interest among patients, physicians, policy makers and funding bodies. However, in the first decade since the concept became widely publicized there have been few completed clinical trials and very few products that have reached the market.

This situation is set to change in the next few years, with a number of major trials completing and several polypill formulations being reviewed by regulatory authorities across the globe.

In order to review key issues regarding regulatory approval, and other major issues such as cost-effectiveness, implementation and research priorities, we are convening the 2nd Cardiovascular Combination Pharmacotherapy Global Summit, to be held in Melbourne, Australia on May 8th, 2014.

The Organizing Committee for the 2014 Polypill Summit includes:

  • Anthony Rodgers, Ruth Webster and Anushka Patel, The George Institute
  • Salim Yusuf, Koon Teo and Tara McCready, Population Health Research Institute (PHRI)
  • Shanthi Mendis, World Health Organisation (WHO)
  • Richard Smith, Ovations Chronic Disease Initiative
  • Sidney Smith, World Heart Federation
  • Valentin Fuster, Mount Sinai
  • Guiseppe Mancia, European Society of Hypertension
  • Andrew Tonkin, Monash University
  • Vanessa Selak and Natasha Rafter, National Institute of Health Innovation

Sponsors

The George Institute for Global Health logo The George Institute for Global Health
Heart Foundation of Australia logo Heart Foundation of Australia

Heart Foundation of New Zealand logo

Heart Foundation of New Zealand
The Lancet logo The Lancet
UnitedHealth logo UnitedHealth
Wellcome Trust logo Wellcome Trust
World Heart Federation logo World Heart Federation

Contact Us

For further information or to RSVP for this event please contact Dr Ruth Webster by email or by phone on +61 2 9993 4557.

Presentation topic: 
Kanyini Guidelines Adherence with the Polypill (Kanyini GAP)
Speaker: 
Presentation file(s): 
Presentation topic: 
UMPIRE trial - Use of a Multidrug Pill In Reducing cardiovascular Events
Speaker: 
SImon Thom
Presentation topic: 
The PolyIran Study: Update - Fixed-Dose Combination Therapy
Speaker: 
Professor Nizal Sarrafzadegan
Presentation file(s): 
Presentation topic: 
Major Trials in Progress HOPE 3, HOPE 4, TIPS 3
Speaker: 
Koon Teo
Presentation topic: 
Overview of International Regulatory Guidelines
Speaker: 
Dr Natasha Rafter
Presentation topic: 
The Whole is Greater Than the Sum of its Parts - Research, Regulation and the Polypill
Speaker: 
Stewart Jessamine
Presentation topic: 
Regulatory approval for polypill in Australia
Speaker: 
Tony Gill
Presentation topic: 
Opportunities and challenges in funding research and development
Speaker: 
Ingmar Wahlqvist
Presentation topic: 
Health and Medical Research: Challenges ARE Opportunities
Speaker: 
Professor Warwick Anderson AM
Presentation topic: 
Opportunities and challenges in funding research and development : Translational Funding at the Wellcome Trust
Speaker: 
Dr Shirshendu Mukherjee
Presentation topic: 
Views of US insurance companies (payers) on the polypill with a few thoughts from NHS England
Speaker: 
Richard Smith
Presentation topic: 
Opportunities for incorporation in government-funded prescribing improvement initiatives
Speaker: 
Neal Maskrey
Presentation topic: 
Polypill uptake in India and Universal Health Care Programs
Speaker: 
D Prabhakaran
Presentation topic: 
Challenges in Commercialisation of Combination pills for Cardiovascular Disease
Speaker: 
Dr Sandeep Bhattacharya
Presentation topic: 
CP-101 CardiaPill The Game Changer in Treating CVD
Speaker: 
Don Summers
Presentation topic: 
Regulatory approval routes in the European System for Medicinal Products
Speaker: 
Kevin Blake